Familial early-onset diabetes is not a typical MODY in several Tunisian patients;Le diabète familial d'apparition précoce n'est pas un MODY typique chez plusieurs patients Tunisiens

Tunisie Medicale

Volumn 90, Issue 12, 2012, Pages 882-887

  Amara, Abdelbasset ^a,b,c   Chadli Chaieb, Molka ^a,b   Ghezaiel, Hela ^b   Philippe, Julien ^d,e   Brahem, Rim ^b   Dechaume, Aurelie ^d,e   Saad, Ali ^b   Chaieb, Larbi ^b   Froguele, Philippe ^e,f   Gribaa, Moez ^b   Vaxillaire, Martine ^d,e  

^a UNIVERSITY OF SOUSSE   (Tunisia)

^b FARHAT HACHED HOSPITAL   (Tunisia)

^c UNIVERSITY OF MONASTIR   (Tunisia)

^d CNRS   (France)

^e UNIV LILLE   (France)

^f HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Early onset diabetes; Genetics; MODY; Mutation; Polymorphism; Tunisian population

Indexed keywords

HEMOGLOBIN A1C; HEPATOCYTE NUCLEAR FACTOR 1ALPHA; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; INSULIN; NEUROGENIC DIFFERENTIATION FACTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; GENE DELETION; GENETIC SCREENING; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN TREATMENT; MISSENSE MUTATION; NON INSULIN DEPENDENT DIABETES MELLITUS; TUNISIA;

ADOLESCENT; ADULT; DIABETES MELLITUS, TYPE 2; HEPATOCYTE NUCLEAR FACTOR 4; HUMANS; MIDDLE AGED; MUTATION, MISSENSE; PEDIGREE; YOUNG ADULT;

EID: 84871308521     PISSN: 00414131     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Vaxillaire M, Froguel P. Monogenic diabetes in the young, pharmacogenetics and relevance to multifactorial forms of type 2 diabetes. Endocr Rev 2008; 29:254-64.
2. Fajans SS, Bell GI. MODY: history, genetics, pathophysiology, and clinical decision making. Diabetes Care 2011; 34:1878-84.
3. Bowman P, Flanagan SE, Edghill EL et al. Heterozygous ABCC8 mutations are a cause of MODY. Diabetologia 2012; 55:123-7.
4. Bonnefond A, Philippe J, Durand E et al. Whole-Exome Sequencing and High Throughput Genotyping Identified KCNJ11 as the Thirteenth MODY Gene. PLoS One 2012; 7:e37423.
5. Chevre JC, Hani EH, Boutin P et al. Mutation screening in 18 Caucasian families suggest the existence of other MODY genes. Diabetologia 1998; 41:1017-23.
6. Bouguerra R, Alberti H, Salem LB et al. The global diabetes pandemic: the Tunisian experience. Eur J Clin Nutr 2007; 61:160-5.
7. Malecki MT, Yang Y, Antonellis A, Curtis S, Warram JH Krolewski AS. Identification of new mutations in the hepatocyte nuclear factor 4alpha gene among families with early onset Type 2 diabetes mellitus. Diabet Med 1999; 16:193-200.
8. Harries LW, Locke JM, Shields B et al. The diabetic phenotype in HNF4A mutation carriers is moderated by the expression of HNF4A isoforms from the P1 promoter during fetal development. Diabetes 2008; 57:1745-52.
9. Eeckhoute J, Briche I, Kurowska M, Formstecher P, Laine B. Hepatocyte nuclear factor 4 alpha ligand binding and F domains mediate interaction and transcriptional synergy with the pancreatic islet LIM HD transcription factor Isl1. J Mol Biol 2006; 364:567-81.
10. Urhammer SA, Hansen T, Ekstrom CT, Eiberg H, Pedersen O. The Ala/Val98 polymorphism of the hepatocyte nuclear factor- 1alpha gene contributes to the interindividual variation in serum C-peptide response during an oral glucose tolerance test: evidence from studies of 231 glucose-tolerant first degree relatives of type 2 diabetic probands. J Clin Endocrinol Metab 1998; 83:4506-9.
11. Shaat N, Karlsson E, Lernmark A et al. Common variants in MODY genes increase the risk of gestational diabetes mellitus. Diabetologia 2006; 49:1545-51.
12. Cinek O, Drevinek P, Sumnik Z et al. NEUROD polymorphism Ala45Thr is associated with Type 1 diabetes mellitus in Czech children. Diabetes Res Clin Pract 2003; 60:49-56.
13. Liu L, Jia W, Zheng T, Li M, Lu H, Xiang K. Ala45Thr variation in neuroD1 gene is associated with early-onset type 2 diabetes with or without diabetic pedigree in Chinese. Mol Cell Biochem 2006; 290:199-204.
14. Bonnefond A, Froguel P, Vaxillaire M. The emerging genetics of type 2 diabetes. Trends Mol Med 2010; 16:407-16.
15. Shields BM, McDonald TJ, Ellard S, Campbell MJ, Hyde C, Hattersley AT. The development and validation of a clinical prediction model to determine the probability of MODY in patients with young-onset diabetes. Diabetologia 2012; 55:1265-72.
16. Ellard S, Bellanne-Chantelot C, Hattersley AT. Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young. Diabetologia 2008; 51:546-53.
17. Bellanne-Chantelot C, Levy DJ, Carette C et al. Clinical characteristics and diagnostic criteria of maturity-onset diabetes of the young (MODY) due to molecular anomalies of the HNF1A gene. J Clin Endocrinol Metab 2011; 96:E1346-51.